Skip to main content

Research News

Pharma Courses
  • Sunbathing after menopause may be harmful

    UV-radiation can affect hormone levels of postmenopausal women negatively and this may contribute to several health issues.
    The concentration of oestrogens in the blood affects a woman’s health in many ways. For example, oestrogens contribute to a strong bone structure and help wounds heal more quickly.

    “When a woman reaches menopause, we see the levels of oestrogens decline and an increase of other hormones, called gonadotropins”, says Kai Triebner at the University of Bergen.

  • Nasal COVID-19 vaccine could soon be a reality

    In a significant development, Bharat Biotech has sought Drug Controller General India's (DCGI) approval to conduct nasal COVID-19 vaccine trials in India. The company has developed a new single-dose nasal COVID-19 vaccine in a partnership with Washington University in St Louis, USA. There are no intra-nasal COVID-19 vaccines under trial in India at the moment.

  • How viruses escape the immune system

    One reason it’s so difficult to produce effective vaccines against some viruses, including influenza and HIV, is that these viruses mutate very rapidly. This allows them to evade the antibodies generated by a particular vaccine, through a process known as “viral escape.”

  • Taurine helps to prevent Bacterial Infection

    Scientists studying the body’s natural defenses against bacterial infection have identified a nutrient taurine that helps the gut recall prior infections and kill invading bacteria, such as Klebsiella pneumoniae (Kpn). The finding, published in the journal Cell by scientists from five institutes of the National Institutes of Health, could aid efforts seeking alternatives to antibiotics.

  • Novel coronavirus found in air samples : CCMB study

    Airborne transmission of the novel coronavirus is possible under certain conditions, cautions a study undertaken by the Centre for Cellular and Molecular Biology (CCMB). The research was conducted to determine the transmission pattern of the virus in various enclosures in hospitals to assess the risks posed to healthcare workers. Air samples were collected from hospitals in Hyderabad and Mohali for the study.

  • New Class of Antibiotics Active Against a Wide Range of Bacteria : Reports

    Wistar Institute scientists have discovered a new class of compounds that uniquely combine direct antibiotic killing of pan drug-resistant bacterial pathogens with a simultaneous rapid immune response for combatting antimicrobial resistance (AMR).

  • Scientists reach new milestone in vaccine development for leishmaniasis

    Researchers have taken an important step forward in developing a controlled human infection model to test leishmaniasis vaccines.

    The University of York-led study identified and characterised a new strain of Leishmania parasite that will form the basis of a new controlled human infection model for the disease which is transmitted by the bite of sand flies. The team then produced the parasite to the standards required for use in human clinical studies.

  • COVAXIN vaccine shows remarkable immunogenicity and protective efficacy against SARS-CoV-2 (new coronavirus). It’s research name is BBV152 which an inactivated SARS-CoV-2 vaccine.

    Two doses vaccination regimen of inactivated SARS-CoV-2 vaccine candidates was administered in 20 rhesus macaques (divided into four groups equally). One group was administered with placebo, while three groups were immunized with 3 different vaccine candidates at 0 and 14 days. All the macaques were exposed to viral challenge 14 days after the 2nd dose. The results showed protective efficacy, increasing SARS-CoV-2 specific IgG and neutralizing antibodies, reducing replication of the virus in the nasal cavity, throat, and lung tissues of monkey.

    No evidence of pneumonia was observed by histopathological examination in vaccinated groups, unlike the placebo group. Adverse events were not seen in animals immunized with a two-dose vaccination regimen.


    Genomic RNA (gRNA) was detected from nasal swab (NS) specimens of all animals in the placebo group from 1 to 7 DPI (Days Post-Infection). Viral clearance was observed in NS specimens of all the animals from the vaccinated group on 7 DPI. Subgenomic RNA (sgRNA) was detected in two of five animals at 3 DPI and one of five animals at 7 DPI of the placebo group.  sgRNA was detected in the NS sample of only one animal of the vaccinated group IV on 5 DPI.

    Neutralizing antibodies and IgG responses were observed from 3rd-week post-immunization in vaccinated groups. IgG titer rose in an increasing pattern with the highest response in group III. The presence of gRNA in NS was observed in the placebo group until 7 DPI. Vaccinated groups had no detectable gRNA in NS on 7 DPI indicating the ability of vaccine candidates to limit upper respiratory tract viral replication, which is a key factor determining the virus transmission.


    gRNA and sgRNA were not detected in the Bronchoalveolar lavage fluid from 5 DPI suggesting that vaccination hindered virus replication and enabled faster clearance from lower airway protecting the animals. gRNA was detected in multiple organs at necropsy in the placebo group, whereas it was found to be cleared in the vaccinated groups.

    Altogether this study demonstrates that a two-dose vaccination regimen using 3µg dose of the vaccine candidate with adjuvant induce a significant immune response and provide effective protection in animals challenged with SARS-CoV-2.

    << Back to Pharma News

    Subscribe to PharmaTutor News Alerts by Email

  • Scientists develop canister bag

    The world was already struggling with some highly infectious diseases like tuberculosis, influenza, when COVID-19 struck. It is a highly transmissible disease and spreads within fraction of a second. Infected patient’s respiratory secretions are highly contagious and there are very high chances of spread of disease through this.

    In a development that could bring huge relief for healthcare professionals, Sree Chitra Institute of Medical Sciences in Thiruvananthapuram has developed canister bags, lined with super-absorbent material containing an effective disinfectant. The bag has been named AcryloSorb. The method is meant for safe handling and disposal of respiratory secretions of patients in Intensive Care Units as well as of those admitted in wards with copious respiratory secretions.

    “Disposal of respiratory secretions of patients suffering from highly contagious diseases such as COVID-19, tuberculosis (TB) and influenza, poses a high risk of infection among healthcare workers. In the canister bags, secretions are sucked into bottles or canisters using vacuum line and discarded through the waste fluid disposal system after subjecting to decontamination process. There is a high risk of contamination during the handling that poses a high risk to health workers. The disposal needs well-equipped sluice rooms with disinfection facilities. The canister bags can absorb 500 ml of secretions and solidify them immediately. And the presence of the disinfectant makes the whole system decontaminated within no time,” says a press statement issued by the institute.


    “ Disposal of respiratory secretions of patients suffering from highly contagious diseases such as COVID-19, tuberculosis (TB) and influenza, poses a high risk of infection among healthcare workers.

    The product has been tested as per international standards and the linear structure has a patented design, the institute states. Field trials of the in-house designed suction canister liner bags are being conducted at the institute. It’s expected to bring the bag to the market at a cost of Rs 100 per bag.


    Sree Chitra Institute claims the canister bag allows easy, spill-proof disposal of the biomedical waste. The press release reads, “Solidification and disinfection inside the bags eliminate the risk of secondary infections by avoiding spilling, and aerosol formation. Canister bags are enclosed in a customizable sealer bag which can pack it as spill-proof decontaminated biomedical waste disposable through incineration.”

    The team that developed the technology include Dr Manju, S, Dr Manoj Komath, Dr Asha Kishore (who is also the Institute Director) and Dr Ajay Prasad Hrishi who are biomaterial scientists and clinicians - The institute has transferred the know-how of the bags to Romsons Scientific and Surgical Private Limited in Uttar Pradesh that produces medical devices.

    << Back to Pharma News

    Subscribe to PharmaTutor News Alerts by Email

  • There was a tragic event that shook the world in the 1960’s, when a large number of babies were born with severe deformities whose mothers had been prescribed a drug called ‘thalidomide’ for morning-sickness. “The problem was a result of the consumption of two enantiomers without separation. One of the isomer was toxic, while the other was the drug”, says Prof. A. S. Achalkumar, Department of Chemistry, IIT Guwahati. Prof Achalkumar and Prof. Yasuhiro Ishida from RIKEN, Wako-shi campus, Japan, have developed a simple and novel method to separate chiral enantiomers.

    Chiral enantiomers are chemicals that have the same molecular formula but different three-dimensional arrangement of the constituent molecular segments. The separation of enantiomers is significant in bio-medical field because many biochemically active chemicals are found as mixtures of two enantiomers, one of which may be beneficial and the other, toxic.

    The chemical properties of enantiomers are similar, which makes it very difficult to separate them, or to synthesize specifically one without being contaminated from the other enantiomer. “Nature is master in the exclusive production of enantiomerically pure amino acids and sugars, but man is still trying to master the art of enantioselective synthesis”, observes Prof Achalkumar. The current method to separate enantiomers is by chromatography, which is slow, energy intensive, and requires environmentally harmful solvents.


    “Nature is master in the exclusive production of enantiomerically pure amino acids and sugars, but man is still trying to master the art of enantioselective synthesis”

    The researchers have separated enantiomers with the use of helical supramolecular polymers. The helical polymers are formed by the salt formation of aromatic carboxylic acid and chiral amino alcohols. In this simple one-pot process they could resolve racemic mixtures into materials rich in one isomer. The interaction sites in supramolecular polymer not only help in the connection of the monomers but also in the recognition of chiral guests. When two salts with the same chirality are mixed, they undergo copolymerization and became soluble, while those with opposite chirality do not form copolymer and hence precipitate. The precipitated compound can be separated easily. The present system can be used for the enantioseparation of the abundant class of chiral amino alcohols, which has huge commercial potential.”


    Prof. Ishida adds that although many supramolecular polymers are known, their enantio-separation ability has never been investigated so far. “Development of such process may help in reducing the price of chiral active pharmaceutical ingredients (APIs) and finally that of the medical treatment, itself. In addition, such process can be extended to other classes of chiral molecules”, he says.

    The group of researchers is led by Prof. A. S. Achalkumar, and Prof. Yasuhiro Ishida from RIKEN, Wako-shi campus, Japan. Their path-breaking work has recently been published in the prestigious journal, Nature Communications. The paper has been co-authored by Prof. Achalkumar, Prof. Ishida, Dr. Vakayil Praveen, Senior Scientist, CSIR-National Institute for Interdisciplinary Science and Technology, and research scholars Dr. Krishnachary Salikolimi, Ms. Kuniyo Yamada, and Dr. Noriko Horimoto. The research findings have been published in the journal, Nature Communications.

    << Back to Pharma News

    Subscribe to PharmaTutor News Alerts by Email

Subscribe to Research News